NeoPeptides™

Complementing our commercial manufacturing and packaging services, we provide a range of commercial storage and distribution solutions for solid oral dosage forms and sterile biopharmaceuticals, for both niche / orphan drug products and large scale commercial market volumes.

Utilising our bespok...

Almac’s peptide and protein technology offering is a key component within our suite of services.  We offer a complete range of peptide and protein services from catalogue products through to GMP manufacture from early phase to commercial launch.  We have a proven track record in high quality supp...

Almac’s experienced formulation scientists can develop a range of oral dose formulations for early stage clinical trials.

With both non-GMP and GMP facilities, flexible and efficient solutions are provided to develop a fit-for-purpose formulation for your early phase clinical trial.
...

Pharmaceutical Product Launch and Distribution
Having successfully partnered in the launch of 15 significant orphan and niche drug products into the EU market over the last 3 years, Almac is the industry leader for Pharmaceutical Product Launch and Distribution.
q...

Serialisation and Track & Trace
Addressing evolving global serialisation legislation, Almac’s expert multi-disciplinary serialisation team lead the way in supporting clients in developing their serialisation strategies to GS1 standards.

...

Arran’s manufacturing range includes fine chemical products for diverse industrial applications and features a range of pharmaceutical intermediates, flavour & fragrance and other personal care products and specialities (including bulk supply of monomers) and chiral amino acids.  Specialised produ...

Almac's Physical Sciences groups' comprehensive range of services and expertise will help strengthen the success of your product. Identifying and consistently producing a drug in its optimal physical form is vital to any successful drug development programme. It also avoids the need for bridging toxicolo...

Enabling Confidence and Security in the Supply Chain

Specialising in solid oral dosage forms, Almac has the technical experience and knowledge to develop robust formulations and manufacturing processes.

We have assisted many of our clients in the development of both immediate and mo...

We are experts in solid state chemistry.Through the creation of synergy between solid state chemistry and formulation development, our experienced scientists have the ability to 

Almac’s strength in API development and manufacture is proven by being the partner of choice for many pharma and biotech companies seeking integrated drug development solutions from molecule to market.

Our technical expertise and extensive facilities enable us to offer integrated API contract ma...

Almac has extensive experience in the synthesis and analysis of stable (non radio-active) and 14C isotope labelled compounds – from drug discovery through to launch – we can label any compound at any stage, including small molecules, peptides and larger bio molecules.

Our custom radiolabell...

Our state-of-the-art analytical testing labs support drug substance (API) and drug product (finished product) analytics across all phases of clinical development and into commercial release.

We employ over 170 highly skilled analysts working in GMP environments across the UK, Europe, and the...

The Almac Group has today announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland meeting client demand in commercial manufacturing and packaging as well as peptide production.

Your integrated API and analytical services provider

The new custom-built facility will consolidate the existing warehouses to support all manufacturing and laboratory activities.

Tailor-made Pharmaceutical Development & Commercial Solutions

Almac Sciences’ Technology Group was selected as the winner of the “Life Sciences Team of the Year” category  during this year’s Irish Life Sciences Awards ceremony, held on 6 July 2023 at Crowne Plaza Hotel, Dublin..

By Dr Colin Lorimer, Formulation Development Manager, Almac Pharma Services

Strengthened collaboration with University College Dublin (UCD) that will focus on the development of novel continuous flow protocols for accessing new industrially relevant drug targets.

With more than 50 years’ experience, we offer a wide range of specialised packaging solutions to meet, and deliver your product launch and ongoing commercial needs.

Overall recognition received for compatibility, expertise, quality and reliability.

Balancing speed with precision, our flexible suite of offerings provides you with a reliable, effective, and expert approach to support the successful and timely introduction and launch of your new product and market penetration into new territories.

Health Products Regulatory Authority (HPRA) has certified Almac Sciences Ireland (ASI) facility for testing of biologics after a successful audit

Our product development service spans early to late phase clinical programs, offering technical experience and dedicated project management, and a track record of on-time delivery from state-of-the-art facilities.

Expanded GMP manufacturing facility now operational for use in clinical and / or commercial manufacturing

Let Almac BOOST your oligo synthesis

Non-GMP & GMP stable & radiolabelling expertise14C labelling of drug substance for human AME studies
Stable & radiolabelled metabolite synthesis
Specialist expertise in peptide & bioconjugate 14C labelling
QC, Analytical & QA integration
MHRA regulatory approved for 14C GMP manufactureof drug substance

Over 30 years’ experience in peptide manufactureRapid throughput, high quality manufacture
Customised supply plan for your project needs
Free consultation on peptide design & manufacturability
Smooth transition to scale-up & cGMP manufacture
Strong emphasis on project management & customercare throughout project lifetime

As a world leader in pharmaceutical services, Almac delivers early formulation development workprograms for DRF/PK/tox studies. Designed to maximise solubility and bioavailability withoutcompromising on chemical stability, the studies accelerate drug development to the clinic and minimizerisk in any downstream activities. Almac offer bespoke work packages specifically tailored to thephysiochemical properties of the API (BCS class II, III, or IV) for solubility or permeability enhancement.